Literature DB >> 31879266

Aptamers as Reversible Sorting Ligands for Preparation of Cells in Their Native State.

Bethany Powell Gray1, Martin D Requena1, Michael D Nichols2, Bruce A Sullenger3.   

Abstract

Although antibodies are routinely used to label and isolate a desired cell type from a more complex mixture of cells, via either fluorescence-activated cell sorting (FACS) or magnetic-activated cell sorting (MACS), such antibody labeling is not easily reversible. We describe an FACS and MACS compatible method to reversibly label and purify cells using aptamers. Magnetic beads loaded with the epidermal growth factor receptor (EGFR)-binding antagonistic aptamer E07 specifically isolated EGFR-expressing cells, and pure, label-free cells were recovered via treatment with an "antidote" oligonucleotide complementary to the aptamer. Additionally, while FACS sorting cells with E07 or EGFR antibody yielded EGFR(+) cells with impeded EGFR signaling, stripping off the aptamer via antidote treatment restored receptor function, returning cells to their native state, which was not possible with the antibody. The ability to reversibly label or isolate cells without compromising their function is a valuable, versatile tool with important implications for both the laboratory and clinic.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  FACS; MACS; antidote; aptamer; cell isolations; cell purification

Mesh:

Substances:

Year:  2019        PMID: 31879266      PMCID: PMC7038790          DOI: 10.1016/j.chembiol.2019.12.004

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  50 in total

1.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase.

Authors:  C Tuerk; L Gold
Journal:  Science       Date:  1990-08-03       Impact factor: 47.728

2.  In vitro selection of RNA molecules that bind specific ligands.

Authors:  A D Ellington; J W Szostak
Journal:  Nature       Date:  1990-08-30       Impact factor: 49.962

Review 3.  Negative depletion of CD3(+) and TcRαβ(+) T cells.

Authors:  Rupert Handgretinger
Journal:  Curr Opin Hematol       Date:  2012-11       Impact factor: 3.284

4.  Detection of single tumor cell resistance with aptamer biochip.

Authors:  Lixue Wang; Qin Zheng; Quan'an Zhang; Hanfeng Xu; Jinlong Tong; Chuandong Zhu; Yuan Wan
Journal:  Oncol Lett       Date:  2012-08-31       Impact factor: 2.967

Review 5.  Treatment of severe autoimmune disease by stem-cell transplantation.

Authors:  Megan Sykes; Boris Nikolic
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

Review 6.  Immunogenicity of engineered antibodies.

Authors:  William Ying Khee Hwang; Jefferson Foote
Journal:  Methods       Date:  2005-05       Impact factor: 3.608

7.  First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.

Authors:  Christopher K Dyke; Steven R Steinhubl; Neal S Kleiman; Richard O Cannon; Laura G Aberle; Min Lin; Shelley K Myles; Chiara Melloni; Robert A Harrington; John H Alexander; Richard C Becker; Christopher P Rusconi
Journal:  Circulation       Date:  2006-11-13       Impact factor: 29.690

8.  Velocity effect on aptamer-based circulating tumor cell isolation in microfluidic devices.

Authors:  Yuan Wan; Jifu Tan; Waseem Asghar; Young-tae Kim; Yaling Liu; Samir M Iqbal
Journal:  J Phys Chem B       Date:  2011-11-07       Impact factor: 2.991

Review 9.  Negative depletion of α/β+ T cells and of CD19+ B lymphocytes: a novel frontier to optimize the effect of innate immunity in HLA-mismatched hematopoietic stem cell transplantation.

Authors:  Franco Locatelli; Aurelie Bauquet; Giuseppe Palumbo; Francesca Moretta; Alice Bertaina
Journal:  Immunol Lett       Date:  2013-09-30       Impact factor: 3.685

10.  Cell separation: Terminology and practical considerations.

Authors:  Matthew J Tomlinson; Sophie Tomlinson; Xuebin B Yang; Jennifer Kirkham
Journal:  J Tissue Eng       Date:  2012-12-28       Impact factor: 7.813

View more
  2 in total

Review 1.  Enhancing CAR-T Cell Therapy with Functional Nucleic Acids.

Authors:  Bruktawit Maru; Lea Nadeau; Maureen McKeague
Journal:  ACS Pharmacol Transl Sci       Date:  2021-11-17

2.  Novel CRISPR-based detection of Leishmania species.

Authors:  Eva Dueñas; Jose A Nakamoto; Luis Cabrera-Sosa; Percy Huaihua; María Cruz; Jorge Arévalo; Pohl Milón; Vanessa Adaui
Journal:  Front Microbiol       Date:  2022-09-15       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.